Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China
A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

NCT05271266

CompletedN/A

Sponsor: AstraZeneca

Conditions: Hyperkalaemia

Countries: China

The study is a multi-center prospective (primary data) non-interventional cohort study which enrolls 1500 patients including new and ongoing users on SZC at Study Enrollment Day in real-world clinical practice. The eligible study patients will be identified by physicians in each study site by assessing the patients or reviewing the medical record. The prescription (including initiation, dose-adjusting or interruption) or discontinuation of SZC will be determined by physicians as per real-world clinical practice and in accordance with the local label. Any AZ employee, or member of the research operation team must not intervene in the decision-making of any physician or patient through any approach, at any time during the study. Every patient will be followed up according to standard clinical practice for 6 months from enrolment.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Age ≥ 18 year-old
* Provision of patient informed consent prior to any study procedure
* HK (sK+ \> 5.0 mmol/L) diagnosed by physicians within 1 year before Study Enrolment Day
* Currently taking SZC, or has been prescribed and agree to start taking SZC since Study Enrolment Day.

Exclusion Criteria:

* Being unable to comply with study-specified procedures
* Has ever participated in current study before, or participating in any interventional study at Study Enrolment Day or within the last 3 months before Study Enrolment Day
Locations (27)
  • Anshan, China
  • Beijing, China
  • Benxi, China
  • Changsha, China
  • Changshu, China
  • Chengdu, China
  • Dalian, China
  • Guangzhou, China
  • Handan, China
  • Hangzhou, China
  • Hefei, China
  • Hohhot, China
  • Jiaxing, China
  • Kunshan, China
  • Linfen, China
  • Nanjing, China
  • Nanyang, China
  • Ningbo, China
  • Qidong, China
  • Shijiazhuang, China
  • Shiyan, China
  • Taian, China
  • Taishing, China
  • Tianjin, China
  • Wenzhou, China
  • Xi'an, China
  • Xinghua, China